Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)

por Matsuyama, Jin, Terazawa, Tetsuji, Goto, Masahiro, Kawabata, Ryohei, Endo, Shunji, Imano, Motohiro, Fujita, Shoichiro, Akamaru, Yusuke, Taniguchi, Hirokazu, Tatsumi, Mitsutoshi, Lee, Sang-Woong, Kawakami, Hisato, Kurokawa, Yukinori, Shimokawa, Toshio, Sakai, Daisuke, Kato, Takeshi, Fujitani, Kazumasa, Satoh, Taroh
Publicado 2022